ERA-话题@MedSci

#ERA#

425篇内容 | 3169人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738936, encodeId=3b441e3893660, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=2019年ASCO-SITC会议：Nektar Therapeutics公布新型Toll样受体激动剂NKTR-262的剂量递增研究, objectType=article, longId=161610, objectId=ccc41616101d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc41616101d, replyNumber=0, likeNumber=60, createdTime=2019-05-27, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc41616101d, moduleTitle=2019年ASCO-SITC会议：Nektar Therapeutics公布新型Toll样受体激动剂NKTR-262的剂量递增研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccc41616101d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738967, encodeId=cee41e3896799, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Onconova Therapeutics和Mission Bio合作推进基于单细胞基因组学的精准肿瘤临床试验, objectType=article, longId=177566, objectId=4cb81e756687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cb81e756687, replyNumber=0, likeNumber=65, createdTime=2020-01-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cb81e756687, moduleTitle=Onconova Therapeutics和Mission Bio合作推进基于单细胞基因组学的精准肿瘤临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cb81e756687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738940, encodeId=66a61e389400f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Seres Therapeutics宣布与AstraZeneca合作探究肠道微生物与肿瘤免疫治疗的协同潜力, objectType=article, longId=162181, objectId=976c162181d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=976c162181d9, replyNumber=0, likeNumber=69, createdTime=2019-09-17, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=976c162181d9, moduleTitle=Seres Therapeutics宣布与AstraZeneca合作探究肠道微生物与肿瘤免疫治疗的协同潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=976c162181d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738937, encodeId=f2ab1e3893741, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Syncona的Nightstar Therapeutics将以8.77亿美元被Biogen收购, objectType=article, longId=161654, objectId=1df1161654bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1df1161654bc, replyNumber=0, likeNumber=55, createdTime=2019-11-08, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1df1161654bc, moduleTitle=Syncona的Nightstar Therapeutics将以8.77亿美元被Biogen收购, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1df1161654bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738957, encodeId=08811e38957ac, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Vertex公司10亿美元收购Exonics Therapeutics，开发神经肌肉疾病的基因疗法, objectType=article, longId=167841, objectId=581816e84163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=581816e84163, replyNumber=0, likeNumber=67, createdTime=2019-12-07, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=581816e84163, moduleTitle=Vertex公司10亿美元收购Exonics Therapeutics，开发神经肌肉疾病的基因疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=581816e84163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738946, encodeId=82d71e38946f1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局, objectType=article, longId=163642, objectId=c3b2163642de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3b2163642de, replyNumber=0, likeNumber=85, createdTime=2019-12-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3b2163642de, moduleTitle=JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3b2163642de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738943, encodeId=a3b61e389432f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=ERAS理念下踝关节骨折诊疗方案优化的专家共识, objectType=article, longId=162675, objectId=8fb31626e5a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fb31626e5a9, replyNumber=0, likeNumber=12, createdTime=2019-11-28, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fb31626e5a9, moduleTitle=ERAS理念下踝关节骨折诊疗方案优化的专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fb31626e5a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738934, encodeId=dc6a1e3893456, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Santhera的Syros在Duchenne型肌营养不良症3期临床研究中大获成功, objectType=article, longId=161123, objectId=fa8c1611239e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa8c1611239e, replyNumber=0, likeNumber=60, createdTime=2019-08-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa8c1611239e, moduleTitle=Santhera的Syros在Duchenne型肌营养不良症3期临床研究中大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa8c1611239e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738971, encodeId=ccc71e38971e3, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, objectType=article, longId=178782, objectId=c6a71e8782a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6a71e8782a5, replyNumber=0, likeNumber=84, createdTime=2019-12-25, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6a71e8782a5, moduleTitle=CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6a71e8782a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738989, encodeId=b7b01e38989d6, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Therapeutic Advances in Gastroenterology：活动性克罗恩病患者的维生素D代谢产物含量较低, objectType=article, longId=184840, objectId=b0cb18484012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0cb18484012, replyNumber=0, likeNumber=64, createdTime=2020-09-06, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0cb18484012, moduleTitle=Therapeutic Advances in Gastroenterology：活动性克罗恩病患者的维生素D代谢产物含量较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0cb18484012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738938, encodeId=29361e38938af, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=口服铁替代疗法Feraccru被证实与静脉注射Ferinject治疗缺铁性贫血患者具有相当的疗效, objectType=article, longId=161662, objectId=464b16166202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=464b16166202, replyNumber=0, likeNumber=89, createdTime=2019-06-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=464b16166202, moduleTitle=口服铁替代疗法Feraccru被证实与静脉注射Ferinject治疗缺铁性贫血患者具有相当的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=464b16166202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738950, encodeId=ed611e389504b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=ACS Appl Mater Interfaces+Theranostics：铁蛋白探针：精准靶向肝癌，使其可视化并杀死肝癌细胞, objectType=article, longId=164904, objectId=efd8164904fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efd8164904fc, replyNumber=0, likeNumber=75, createdTime=2019-09-08, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efd8164904fc, moduleTitle=ACS Appl Mater Interfaces+Theranostics：铁蛋白探针：精准靶向肝癌，使其可视化并杀死肝癌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efd8164904fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738972, encodeId=51031e389722a, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=ERAS理念下高龄患者髋部骨折再发急性心肌梗死围术期处理1例, objectType=article, longId=179845, objectId=798c1e9845e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=798c1e9845e5, replyNumber=0, likeNumber=66, createdTime=2020-04-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=798c1e9845e5, moduleTitle=ERAS理念下高龄患者髋部骨折再发急性心肌梗死围术期处理1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=798c1e9845e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738935, encodeId=e06a1e389357b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Arthritis Research & Therapy：阜外医院大规模儿童大动脉炎研究：半数在5年内复发，肾动脉受累常见, objectType=article, longId=161268, objectId=e10016126827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e10016126827, replyNumber=0, likeNumber=76, createdTime=2019-12-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e10016126827, moduleTitle=Arthritis Research & Therapy：阜外医院大规模儿童大动脉炎研究：半数在5年内复发，肾动脉受累常见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e10016126827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738926, encodeId=b2241e3892675, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：**计算重症患者万古霉素曲线下面积选哪种工具为宜？, objectType=article, longId=156871, objectId=10171568e1e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10171568e1e8, replyNumber=0, likeNumber=70, createdTime=2019-09-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10171568e1e8, moduleTitle=Pharmacotherapy：**计算重症患者万古霉素曲线下面积选哪种工具为宜？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10171568e1e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738948, encodeId=2af81e38948f5, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, objectType=article, longId=164365, objectId=dbfc16436511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbfc16436511, replyNumber=0, likeNumber=67, createdTime=2019-06-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbfc16436511, moduleTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbfc16436511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738923, encodeId=ec361e389239a, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cancer Gene Therapy：ERCC6L能够增强细胞活力和促进肿瘤生长, objectType=article, longId=156331, objectId=fd27156331d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd27156331d0, replyNumber=0, likeNumber=90, createdTime=2019-11-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd27156331d0, moduleTitle=Cancer Gene Therapy：ERCC6L能够增强细胞活力和促进肿瘤生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd27156331d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738929, encodeId=1bbd1e3892968, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Semin Arthritis Rheu：无症状高尿酸血症患者OMERACT定义的痛风基本超声病变的患病率和辨别度, objectType=article, longId=158112, objectId=99a015811200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99a015811200, replyNumber=0, likeNumber=49, createdTime=2019-08-11, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99a015811200, moduleTitle=Semin Arthritis Rheu：无症状高尿酸血症患者OMERACT定义的痛风基本超声病变的患病率和辨别度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99a015811200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738958, encodeId=cb721e38958a0, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cancer Gene Therapy：BMP1过表达反应了透明细胞肾细胞肿瘤的不良预后, objectType=article, longId=168472, objectId=8af71684e287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8af71684e287, replyNumber=0, likeNumber=72, createdTime=2019-11-11, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8af71684e287, moduleTitle=Cancer Gene Therapy：BMP1过表达反应了透明细胞肾细胞肿瘤的不良预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8af71684e287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738964, encodeId=08551e389645e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Knight Therapeutics的Neratinib成为第一个在加拿大获批的抗HER2疗法，用于激素受体阳性、HER2阳性早期乳腺癌的延长辅助治疗, objectType=article, longId=175669, objectId=17911e5669f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17911e5669f5, replyNumber=0, likeNumber=64, createdTime=2019-08-29, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17911e5669f5, moduleTitle=Knight Therapeutics的Neratinib成为第一个在加拿大获批的抗HER2疗法，用于激素受体阳性、HER2阳性早期乳腺癌的延长辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17911e5669f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

2019年ASCO-SITC会议：Nektar Therapeutics公布新型Toll样受体激动剂NKTR-262的剂量递增研究

2019-05-27

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Onconova Therapeutics和Mission Bio合作推进基于单细胞基因组学的精准肿瘤临床试验

2020-01-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Seres Therapeutics宣布与AstraZeneca合作探究肠道微生物与肿瘤免疫治疗的协同潜力

2019-09-17

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Syncona的Nightstar Therapeutics将以8.77亿美元被Biogen收购

2019-11-08

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Vertex公司10亿美元收购Exonics Therapeutics，开发神经肌肉疾病的基因疗法

2019-12-07

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

JACC：评估一种新型自扩张经导管心脏瓣膜CENTERA-EU试验的1年结局

2019-12-16

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

ERAS理念下踝关节骨折诊疗方案优化的专家共识

2019-11-28

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Santhera的Syros在Duchenne型肌营养不良症3期临床研究中大获成功

2019-08-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

CARsgen Therapeutics公司的多发性骨髓瘤CAR-T细胞疗法喜获FDA的孤儿药物指定

2019-12-25

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Therapeutic Advances in Gastroenterology：活动性克罗恩病患者的维生素D代谢产物含量较低

2020-09-06

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

口服铁替代疗法Feraccru被证实与静脉注射Ferinject治疗缺铁性贫血患者具有相当的疗效

2019-06-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

ACS Appl Mater Interfaces+Theranostics：铁蛋白探针：精准靶向肝癌，使其可视化并杀死肝癌细胞

2019-09-08

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

ERAS理念下高龄患者髋部骨折再发急性心肌梗死围术期处理1例

2020-04-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Arthritis Research & Therapy：阜外医院大规模儿童大动脉炎研究：半数在5年内复发，肾动脉受累常见

2019-12-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：**计算重症患者万古霉素曲线下面积选哪种工具为宜？

2019-09-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性

2019-06-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cancer Gene Therapy：ERCC6L能够增强细胞活力和促进肿瘤生长

2019-11-05

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Semin Arthritis Rheu：无症状高尿酸血症患者OMERACT定义的痛风基本超声病变的患病率和辨别度

2019-08-11

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cancer Gene Therapy：BMP1过表达反应了透明细胞肾细胞肿瘤的不良预后

2019-11-11

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Knight Therapeutics的Neratinib成为第一个在加拿大获批的抗HER2疗法，用于激素受体阳性、HER2阳性早期乳腺癌的延长辅助治疗

2019-08-29

科室
- - 订阅+
  - 更多科室
工具
服务